Recent research has focused on targeting SASP for therapeutic purposes. Strategies include the use of senolytics, which selectively eliminate senescent cells, and senomorphics, which modulate the SASP profile without killing the cells. By reducing the harmful effects of SASP, these therapies hold promise for treating age-related diseases and extending healthy lifespan.
